The Bioabsorbables/Bioresorbables Center

Filter Your Results

 

News

 

Novel Drug-Eluting Coronary Stents Nearing Approval in the United States

Dean J. Kereiakes, MD, FACC

July/August 2011—New stent platforms may offer enhanced performance, safety, and efficacy characteristics.

New DES Platforms

Barbara Huibregtse, DVM, and Juan F. Granada, MD

July/August 2011—Does the metal alloy matter?

The DES Landscape in 2011

Jeffrey S. Kunz, MD, and Mark A. Turco, MD, FACC, FSCAI

January/February 2011—Future directions in drug-eluting stent design.

Boston Scientific Completes EVOLVE Enrollment

January 24, 2011 -- Boston Scientific Corporation (Natick, MA) announced the completion of patient enrollment in the EVOLVE clinical trial, which is designed to assess the saf…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.